Beacon Capital Management LLC (Tennessee)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10	Closed	-$2K	–	1027
2023 Q1	$2K	Hold	10	–	–	﹤0.01%	763
2022 Q4	$2.38K	Buy	+10	New	+$2.38K	﹤0.01%	769